Alcimed has been exploring the consumer healthcare market for more than 25 years and supports its clients in their innovation projects, in understanding the scientific mechanisms of key concepts, finding partners, international development, creation of new models and construction of new consumer healthcare offerings. Working at the interface of different sectors, Alcimed uses its experience in the fields of healthcare, cosmetics, agri-food, energy, and many others to help you explore and develop your uncharted territories in the field of CHC.
They trust us
The challenges related to consumer healthcare
The consumer healthcare market is booming, driven by an aging population, the multiplication of wellness-related products and services, the proliferation of health information sources, consumers’ desire to control their health and healthy aging.
This market is growing worldwide: we predict a global CAGR of 9% within 3 years, driven by North America, Europe and Asia-Pacific. The arrival of a growing number of different players from the world of cosmetics, agrifood, FMCGs, start-ups, etc., as well as regulatory changes, the growing consumer appeal for digital technology and their ecological awareness, are shaping the challenges of this market.
At Alcimed, we have identified four major trends shaping this consumer healthcare environment:
- Personalization, through data, which makes it possible to offer consumers increasingly personalized care centered on their needs. For example, the French company Cuure, which sells food supplements online, allows consumers to receive personalized care products at home, based on responses to a questionnaire around their needs and goals.
- Holistic well–being, which makes it possible to act not only on physical health but also on mental needs and well beyond. For example, Withings has a personalized offer combining connected devices and mobile applications to collect and visualize patient data to improve their well-being and health.
- New consumption habits, which are changing data, particularly with the digitization accelerated by COVID-19. Many consumers turned to online health purchases, developing the e-commerce market, which should reach 1,000 billion dollars in 2022. For example, Amazon acquired PillPack, which launched a site offering the delivery of packaged and dosed drugs. The platform is based on in-house software that manages patient data and balances drug doses in a secure way for its customers. We can also mention the growing use of teleconsultation, brought in France by the unicorn Doctolib or the Polish DocPlanner.
- Finally, consumers are increasingly aware of their ecological impact, which is becoming an essential element in the consumer healthcare Many consumers change their purchasing behavior based on sustainability factors: they are looking for alternative natural plant-based options, products that are more transparent in terms of ingredient origin and composition with reduced environmental impact. Not only are customers proactively looking for sustainable options, they are increasingly willing to pay for them. In addition, the B Corp label, certifying environmental commitment, is gaining more and more importance in France, and Laboratories Expanscience and Chiesi are the first in the world to carry this certification.
While this consumer healthcare market is growing, there are many challenges for healthcare manufacturers and players in this consumer healthcare ecosystem. These challenges include:
Proximity to the specific needs of consumers at the local level is a critical issue in consumer healthcare, in order to fully understand the expectations of the local market (like what is already made in agri-food) and to develop offers adapted accordingly.
How do we collect the voice of consumers and integrate it into the development of offers more adapted to the local level? How do we develop organizational innovation models in a geographic R&D hub that remain aligned to local realities?
The rising prevalence of chronic diseases, which are defined by the WHO as “any health problem that requires management over a period of years or decades” is pushing governments and payers to invest in preventative care. At the same time, increasingly well-informed consumers are opting for more active management of their own health, and are turning to self-medication products capable of maintaining their state of health and well-being.
How do we imagine new preventative care solutions? How do we reposition products for the purpose of prevention? How do we imagine the new prevention business models and the operators to work with (insurers, etc.)?
The rise of new technologies gives more power to consumers; multiple solutions such as “wearables” (connected watches like the Apple Watch or even connected bands like Dreem, a bracelet that helps insomniacs get quality sleep) or teleconsultation, are becoming more common and allow consumers to find alternatives to the traditional approach to health care. Pharmaceutical laboratories and other consumer healthcare players must therefore adapt and innovate to fit into this increasingly digital consumer healthcare journey.
What are the most relevant new technologies to continue to meet consumer needs? What integrated consumer health services or solutions should be offered? What type of player or company should we partner with, and how? What are the associated business models?
Among the major pharmaceutical groups, there is a tendency to separate consumer healthcare activities from the rest of the pharmaceutical activities, in order to refocus pharmaceutical activities on a restricted core business and give free rein to consumer healthcare teams to develop innovation and focus on these new consumer needs. After Sanofi and the creation of an independent Opella entity, it is GSK’s turn in 2022 to engage in this movement by creating Haleon. These changes are pushing players to rethink their growth and portfolio strategy, adjust their innovation cycles and overcome regulatory and technological barriers to create a unique value proposition and conquer their markets.
What value proposition can be developed to highlight the scientific history of a pharmaceutical laboratory while getting closer to the FMCG world with consumer healthcare? How do we unleash innovation in a purely CHC group?
How we support you in your projects related to consumer healthcare
Our team carries out more than 80 projects per year with our consumer healthcare clients, both globally and locally, from R&D to commercial operations (Open Innovation, Marketing, Medical, Consumer and Market Insights, Market Access, Strategy, etc. .).
We work for the pharmaceutical industry (Sanofi, Pfizer, GSK, etc.), CHC industrial players (Sanofi CHC, Expanscience, UPSA, etc.), cosmetics players (L’Oréal, Pierre Fabre, etc.), agri-food players (Danone, Nestlé, etc.) but also research centers, HealthTech players or national and European institutions.
Our unique approach is based on our ability to deploy Alcimed’s strengths: exploring complex and multi-sectoral themes, comparing different points of view, building new offers, imagining what does not exist today, drawing inspiration from what is done by others or in other fields, and capturing the voice of consumers to feed the reflections.
We thus work on different types of projects: developing new consumer healthcare offers, finding new partners, creating new models, mapping new technologies, exploring new geographies, deciphering new trends… and many more!
Examples of recent projects carried out for our clients in consumer healthcare
Study of trends and technologies in the allergy field for a consumer healthcare player
Our team supported our client, a consumer healthcare player, in identifying opportunities in the field of allergy monitoring.
We have carried out a comprehensive market study of existing solutions and trends in the field of allergy and air quality covering a large number of different technologies.
The results of our investigation made it possible to identify a start-up developing an appropriate air quality sensor to couple with a mobile application for monitoring allergies, and to imagine the best possible business model for our client.
Development of a new pharmacy consultation service offer for a consumer healthcare player
Our client, a consumer healthcare player, wanted to develop a pharmacy consultation service offer in France.
To do this, our team first produced an overview of the pharmacy consultation offers available and analyzed their financing solution and their perception by pharmacists. We also capitalized on their feedback and identified the best practices to be put in place to operationally provide such a solution in pharmacies by overcoming the identified barriers.
Finally, the most interesting consulting offers for our client were developed in business cases and associated with their specific roadmap.
Study of the potential of the gut-brain axis in consumer healthcare
Our client, a consumer healthcare player, wanted support in revitalizing its pain product based on the concept of the gut-brain axis.
Our support initially consisted in understanding the subject from a medical and scientific point of view, and in carrying out an objective state of the art. This made it possible not only to select the most relevant arguments for repositioning the drug in question in this field, but also to identify the key research players to go further. We then rewrote the associated product claims with the local internal marketing and medical teams in several workshops.
Our work finished with the development of a scientifically sound and impactful pitch.
Search for partners capable of producing natural melatonin
We supported one of our clients, a pharmaceutical company, in identifying and evaluating potential partners capable of providing natural alternatives to synthetic melatonin.
To do this, our team drew up a state of the art of patents and existing technologies on the market, and discussed with many experts to identify the technologies in development. We were thus able to use the results of our research to select the most appropriate actors to develop a partnership with our client and initiated the first contacts.
You have a project?
To go further
What are the new offers to develop to adapt to the new consumer healthcare trends?
The consumer healthcare market is rapidly evolving. New needs and customer profiles are emerging. So what are the key consumer healthcare trends?
Training for medical devices used at home: 4 key points to understand this need for personalized training
At home, medical devices are intended to be handled by the patient or their health professional, yet there is little training for there use today, even though medical devices are crucial in certain ...
The growing role of pharmacists within patients pathway: what implications for pharma companies?
The role of the pharmacist is growing in many European countries, not only for over-the-counter but also for prescription medications. Alcimed, an innovation & new business consulting firm, has ...
Founded in 1993, Alcimed is an innovation and new business consulting firm, specializing in innovation driven sectors: life sciences (healthcare, biotech, agrifood), energy, environment, mobility, chemicals, materials, cosmetics, aeronautics, space and defence.
Our purpose? Helping both private and public decision-makers explore and develop their uncharted territories: new technologies, new offers, new geographies, possible futures, and new ways to innovate.
Located across eight offices around the world (France, Europe, Singapore and the United States), our team is made up of 220 highly-qualified, multicultural and passionate explorers, with a blended science/technology and business culture.
Our dream? To build a team of 1,000 explorers, to design tomorrow’s world hand in hand with our clients.
Consumer Health Care, or CHC, brings together all the health products and self-medication services available over the counter (OTC), which are aimed at prevention through to the treatment of a pathology, including diagnosis and follow-up.